Last reviewed · How we verify
NCT07161557
Evaluating Metabolic Health in People Aged 18 to 60 by Nutrilite Metabolic Health Index
trial testing No Intervention: Observational Cohort in Metabolic Abnormality in 200 participants. Not yet recruiting.
10 April 2026
Quick facts
| Lead sponsor | Amway (China) R&D Center |
|---|---|
| Status | Not yet recruiting |
| Study type | OBSERVATIONAL |
| Enrollment | 200 |
| Start date | 9 October 2025 |
| Primary completion | 10 April 2026 |
| Estimated completion | 10 May 2026 |
| Sites | 1 location across China |
Drugs / interventions tested
- No Intervention: Observational Cohort — full drug profile →
Conditions studied
- Metabolic Abnormality — all drugs for Metabolic Abnormality →
- Metabolic Disorders — all drugs for Metabolic Disorders →
Sponsor
Amway (China) R&D Center
Who can join
Adults 18 to 60, any sex, with Metabolic Abnormality or Metabolic Disorders. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The goal of this observational study is to evaluate Metabolic Health by fit analysis between calculated Nutrilite Metabolic Health Index and the result of Metabolomics analysis from blood plasma samples in healthy adult participants aged between 18 and 60 years. The main question it aims to answer: \- Does the Nutrilite Metabolic Health Index fit well with the result of Metabolomics analysis from blood plasma samples? 200 eligible participants will be enrolled in a single center, one site visit will be made to finish a health questionnaire, a lifestyle questionnaire, a routine physical checkup. Blood samples will be collected for routine blood test (blood sugar, total triglycerides, total cholesterol, low-density lipoprotein cholesterol, high-density lipoprotein cholesterol, uric acid), and for Metabolomics testing. Researchers will calculate the Nutrilite Metabolic Health Index based on participant data, and do the fit analysis against the result from Metabolomics analysis.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07161557
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of No Intervention: Observational Cohort
Trials testing the same drug.
- NCT07284771 — MUSCLE-ML: Multimodal Integration of Muscle Strength, Structure by Machine Learning for Precision Rehabilitation After A · not yet recruiting
- NCT07414160 — Association Between Dynamic Prealbumin Trajectories and Prognosis in Critically Ill Patients · not yet recruiting
- NCT07481188 — Frailty and Nottingham Hip Fracture Score for Predicting 90-Day Mortality After Hip Fracture Surgery · recruiting
- NCT07475468 — CP382 - Intermittent Catheter (IC) PRO Panel Plan · not yet recruiting
- NCT07382570 — Natural Course of Congenital Hydronephrosis in Infants Aged 0-6 Months · not yet recruiting
Other recruiting trials for Metabolic Abnormality
Currently open trials in the same condition.
- NCT07514377 — JiGenerations Health Cohort Study：Parental Exposure and Intergenerational Health in China · active not recruiting
- NCT06835426 — High-resolution PET-CT Specimen Imaging for the Perioperative Visualization of Resection Margins · NA · recruiting
Other Amway (China) R&D Center trials
Trials by the same sponsor.
- NCT06499012 — The Efficacy of Nutrilite All-plant Protein Booster to Improve Sarcopenia and Osteoarthritis in Middle-aged and Elderly · NA · completed
- NCT07094022 — Improvement and Safety of Nutrilite Protein MetX Pro on Weight Management in Overweight Individuals With Dyslipidemia · NA · completed
- NCT06084585 — The Efficacy of Amway Uric Acid Lowering Product on Hyperuricemia · NA · unknown
- NCT05986799 — The Efficacy of Amway Herbal Drink to Improve Skin Anti-aging · NA · unknown
- NCT05872360 — To Investigate Effects of Amway Bundle Combination of Products on Osteoarthritis & Sarcopenia · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07161557 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Amway (China) R&D Center
- Last refreshed: 12 September 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07161557.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing